rdf:type |
|
lifeskim:mentions |
umls-concept:C0006560,
umls-concept:C0029408,
umls-concept:C0087111,
umls-concept:C0119860,
umls-concept:C0172537,
umls-concept:C0229671,
umls-concept:C0311395,
umls-concept:C0427716,
umls-concept:C0441655,
umls-concept:C0601900,
umls-concept:C1280500,
umls-concept:C1280551,
umls-concept:C1304757,
umls-concept:C1456376
|
pubmed:issue |
8
|
pubmed:dateCreated |
2007-8-2
|
pubmed:abstractText |
To investigate the effects of polysulfated glycosaminoglycan (PSGAG) treatment on serum cartilage oligomeric matrix protein (COMP) concentration, matrix metal-loproteinase-2 (MMP-2) and -9 (MMP-9) activities, C-reactive protein (CRP) concentration, and lameness scores in dogs with osteoarthritis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0002-9645
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
827-33
|
pubmed:meshHeading |
pubmed-meshheading:17669022-Animals,
pubmed-meshheading:17669022-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:17669022-C-Reactive Protein,
pubmed-meshheading:17669022-Dog Diseases,
pubmed-meshheading:17669022-Dogs,
pubmed-meshheading:17669022-Extracellular Matrix Proteins,
pubmed-meshheading:17669022-Glycoproteins,
pubmed-meshheading:17669022-Glycosaminoglycans,
pubmed-meshheading:17669022-Lameness, Animal,
pubmed-meshheading:17669022-Matrix Metalloproteinase 2,
pubmed-meshheading:17669022-Matrix Metalloproteinase 9,
pubmed-meshheading:17669022-Osteoarthritis
|
pubmed:year |
2007
|
pubmed:articleTitle |
Effects of treatment with polysulfated glycosaminoglycan on serum cartilage oligomeric matrix protein and C-reactive protein concentrations, serum matrix metalloproteinase-2 and -9 activities, and lameness in dogs with osteoarthritis.
|
pubmed:affiliation |
Laboratory of Veterinary Surgery, Department of Veterinary Medicine, Kagoshima University, 1-21-24 Korimoto, Kagoshima 890-0065, Japan.
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|